ArticleArchives of medical science : AMS2025
Assessing the impact of a wheat flour and baker's yeast restricted diet vs. calorie restriction in non-alcoholic fatty liver disease patients.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Short-term synbiotic supplementation and intrahepatic triglyceride content assessed by proton MR spectroscopy: a pilot study.BMC gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a prevalent and nonalcoholic, progressive liver disorder associated with metabolic disturbance. This study aimed to compare the efficacy of a wheat flour or baker's yeast restricted diet with traditional calorie restriction in NAFLD patients. Material and methods: The analysed data were obtained from 243 individuals with NAFLD, who completed the study. Of these patients, 54 belonged to Group (1) (standard diet, SD), 104 belonged to Group (2) (wheat flour-free diet, WFFD), and 85 belonged to Group (3) (yeast-free diet, YFD). The intervention period lasted 6 months, during which participants' dietary compliance was closely monitored. Anthropometric measurements, liver function tests, and imaging studies were conducted at baseline, after 3 months, and at the endpoint. Results: At the end of the 6-month trial, both the WFFD and YFD groups exhibited a noteworthy reduction in body mass index (BMI) and triglyceride (TG) levels when compared to a standard diet that only involved calorie restriction. Furthermore, a notable reduction in the severity of liver steatosis was seen in these groups ( Conclusions: This study highlights the significance of food constituents and dietary strategies in the treatment of NAFLD. It suggests that limiting the intake of wheat flour and baker's yeast specifically could have positive effects on liver well-being. Nevertheless, it is imperative to conduct comprehensive and enduring investigations that consider the genetic and metabolic variations among individuals. The results of this study provide evidence that customised dietary approaches designed to meet people's specific nutritional requirements could be crucial in the treatment of NAFLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.